APNB Insider Trading Activity and SEC Form 4 Filings
APNB insider trading summary
No open-market insider purchases or sales of AspenBio Pharma, Inc. (APNB) have been reported on SEC Form 4 in the past 12 months.
Latest APNB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 29, 2007 | Douglas I Hepler | Director | Sell | $3K (500 @ $5.95) |
| Aug 29, 2007 | Douglas I Hepler | Director | Sell | $24K (4,000 @ $6.00) |
| Aug 29, 2007 | Douglas I Hepler | Director | Sell | $3K (500 @ $5.80) |
| Aug 16, 2007 | Richard G Donnelly | President & CEO | Buy | $9K (2,000 @ $4.60) |
| Jul 18, 2007 | 1837 Partners QP L.P. | 10% Owner | Sell | $137K (25,140 @ $5.43) |
| Jul 18, 2007 | 1837 Partners Ltd. | 10% Owner | Sell | $137K (25,140 @ $5.43) |
| Jul 18, 2007 | 1837 Partners L.P. | 10% Owner | Sell | $34K (6,330 @ $5.43) |
| Jul 18, 2007 | 1837 Partners L.P. | 10% Owner | Sell | $137K (25,140 @ $5.43) |
| Jul 18, 2007 | 1837 RMB Managers L.L.C. | 10% Owner | Sell | $137K (25,140 @ $5.43) |
| Jul 18, 2007 | 1837 RMB Managers L.L.C. | 10% Owner | Sell | $33K (6,030 @ $5.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.